Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Endometriosis Treatment Drugs Market Growth 2022-2028

  • LP 4917317
  • 106 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Endometriosis Treatment Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Endometriosis Treatment Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Endometriosis Treatment Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Endometriosis Treatment Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Endometriosis Treatment Drugs market, reaching US$ million by the year 2028. As for the Europe Endometriosis Treatment Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Endometriosis Treatment Drugs players cover AbbVie Inc, Bayer AG, AstraZeneca, and Pfizer Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Endometriosis Treatment Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral Type

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

E-Commerce

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AbbVie Inc

Bayer AG

AstraZeneca

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Ipsen Pharma

Myovant Sciences Ltd

Endoceutics, Inc

Debiopharm Group

Mayne Pharma Group

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Endometriosis Treatment Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Endometriosis Treatment Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Endometriosis Treatment Drugs by Country/Region, 2017, 2022 & 2028

2.2 Endometriosis Treatment Drugs Segment by Type

2.2.1 Oral Type

2.2.2 Others

2.3 Endometriosis Treatment Drugs Sales by Type

2.3.1 Global Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Endometriosis Treatment Drugs Sale Price by Type (2017-2022)

2.4 Endometriosis Treatment Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 E-Commerce

2.4.4 Others

2.5 Endometriosis Treatment Drugs Sales by Application

2.5.1 Global Endometriosis Treatment Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Endometriosis Treatment Drugs Sale Price by Application (2017-2022)

3 Global Endometriosis Treatment Drugs by Company

3.1 Global Endometriosis Treatment Drugs Breakdown Data by Company

3.1.1 Global Endometriosis Treatment Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Endometriosis Treatment Drugs Sales Market Share by Company (2020-2022)

3.2 Global Endometriosis Treatment Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Endometriosis Treatment Drugs Revenue by Company (2020-2022)

3.2.2 Global Endometriosis Treatment Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Endometriosis Treatment Drugs Sale Price by Company

3.4 Key Manufacturers Endometriosis Treatment Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Endometriosis Treatment Drugs Product Location Distribution

3.4.2 Players Endometriosis Treatment Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Endometriosis Treatment Drugs by Geographic Region

4.1 World Historic Endometriosis Treatment Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Endometriosis Treatment Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Endometriosis Treatment Drugs Annual Revenue by Geographic Region

4.2 World Historic Endometriosis Treatment Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Endometriosis Treatment Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Endometriosis Treatment Drugs Annual Revenue by Country/Region

4.3 Americas Endometriosis Treatment Drugs Sales Growth

4.4 APAC Endometriosis Treatment Drugs Sales Growth

4.5 Europe Endometriosis Treatment Drugs Sales Growth

4.6 Middle East & Africa Endometriosis Treatment Drugs Sales Growth

5 Americas

5.1 Americas Endometriosis Treatment Drugs Sales by Country

5.1.1 Americas Endometriosis Treatment Drugs Sales by Country (2017-2022)

5.1.2 Americas Endometriosis Treatment Drugs Revenue by Country (2017-2022)

5.2 Americas Endometriosis Treatment Drugs Sales by Type

5.3 Americas Endometriosis Treatment Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Endometriosis Treatment Drugs Sales by Region

6.1.1 APAC Endometriosis Treatment Drugs Sales by Region (2017-2022)

6.1.2 APAC Endometriosis Treatment Drugs Revenue by Region (2017-2022)

6.2 APAC Endometriosis Treatment Drugs Sales by Type

6.3 APAC Endometriosis Treatment Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Endometriosis Treatment Drugs by Country

7.1.1 Europe Endometriosis Treatment Drugs Sales by Country (2017-2022)

7.1.2 Europe Endometriosis Treatment Drugs Revenue by Country (2017-2022)

7.2 Europe Endometriosis Treatment Drugs Sales by Type

7.3 Europe Endometriosis Treatment Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Endometriosis Treatment Drugs by Country

8.1.1 Middle East & Africa Endometriosis Treatment Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Endometriosis Treatment Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Endometriosis Treatment Drugs Sales by Type

8.3 Middle East & Africa Endometriosis Treatment Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Endometriosis Treatment Drugs

10.3 Manufacturing Process Analysis of Endometriosis Treatment Drugs

10.4 Industry Chain Structure of Endometriosis Treatment Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Endometriosis Treatment Drugs Distributors

11.3 Endometriosis Treatment Drugs Customer

12 World Forecast Review for Endometriosis Treatment Drugs by Geographic Region

12.1 Global Endometriosis Treatment Drugs Market Size Forecast by Region

12.1.1 Global Endometriosis Treatment Drugs Forecast by Region (2023-2028)

12.1.2 Global Endometriosis Treatment Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Endometriosis Treatment Drugs Forecast by Type

12.7 Global Endometriosis Treatment Drugs Forecast by Application

13 Key Players Analysis

13.1 AbbVie Inc

13.1.1 AbbVie Inc Company Information

13.1.2 AbbVie Inc Endometriosis Treatment Drugs Product Offered

13.1.3 AbbVie Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Inc Main Business Overview

13.1.5 AbbVie Inc Latest Developments

13.2 Bayer AG

13.2.1 Bayer AG Company Information

13.2.2 Bayer AG Endometriosis Treatment Drugs Product Offered

13.2.3 Bayer AG Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer AG Main Business Overview

13.2.5 Bayer AG Latest Developments

13.3 AstraZeneca

13.3.1 AstraZeneca Company Information

13.3.2 AstraZeneca Endometriosis Treatment Drugs Product Offered

13.3.3 AstraZeneca Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AstraZeneca Main Business Overview

13.3.5 AstraZeneca Latest Developments

13.4 Pfizer Inc

13.4.1 Pfizer Inc Company Information

13.4.2 Pfizer Inc Endometriosis Treatment Drugs Product Offered

13.4.3 Pfizer Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Inc Main Business Overview

13.4.5 Pfizer Inc Latest Developments

13.5 Teva Pharmaceutical Industries Ltd

13.5.1 Teva Pharmaceutical Industries Ltd Company Information

13.5.2 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Offered

13.5.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Teva Pharmaceutical Industries Ltd Main Business Overview

13.5.5 Teva Pharmaceutical Industries Ltd Latest Developments

13.6 Ipsen Pharma

13.6.1 Ipsen Pharma Company Information

13.6.2 Ipsen Pharma Endometriosis Treatment Drugs Product Offered

13.6.3 Ipsen Pharma Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ipsen Pharma Main Business Overview

13.6.5 Ipsen Pharma Latest Developments

13.7 Myovant Sciences Ltd

13.7.1 Myovant Sciences Ltd Company Information

13.7.2 Myovant Sciences Ltd Endometriosis Treatment Drugs Product Offered

13.7.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Myovant Sciences Ltd Main Business Overview

13.7.5 Myovant Sciences Ltd Latest Developments

13.8 Endoceutics, Inc

13.8.1 Endoceutics, Inc Company Information

13.8.2 Endoceutics, Inc Endometriosis Treatment Drugs Product Offered

13.8.3 Endoceutics, Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Endoceutics, Inc Main Business Overview

13.8.5 Endoceutics, Inc Latest Developments

13.9 Debiopharm Group

13.9.1 Debiopharm Group Company Information

13.9.2 Debiopharm Group Endometriosis Treatment Drugs Product Offered

13.9.3 Debiopharm Group Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Debiopharm Group Main Business Overview

13.9.5 Debiopharm Group Latest Developments

13.10 Mayne Pharma Group

13.10.1 Mayne Pharma Group Company Information

13.10.2 Mayne Pharma Group Endometriosis Treatment Drugs Product Offered

13.10.3 Mayne Pharma Group Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mayne Pharma Group Main Business Overview

13.10.5 Mayne Pharma Group Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Endometriosis Treatment Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Endometriosis Treatment Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Type

Table 4. Major Players of Others

Table 5. Global Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Endometriosis Treatment Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Endometriosis Treatment Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Endometriosis Treatment Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Endometriosis Treatment Drugs Revenue by Application (2017-2022)

Table 13. Global Endometriosis Treatment Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Endometriosis Treatment Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Endometriosis Treatment Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Endometriosis Treatment Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Endometriosis Treatment Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Endometriosis Treatment Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Endometriosis Treatment Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Endometriosis Treatment Drugs Producing Area Distribution and Sales Area

Table 21. Players Endometriosis Treatment Drugs Products Offered

Table 22. Endometriosis Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Endometriosis Treatment Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Endometriosis Treatment Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Endometriosis Treatment Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Endometriosis Treatment Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Endometriosis Treatment Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Endometriosis Treatment Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Endometriosis Treatment Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Endometriosis Treatment Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Endometriosis Treatment Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Endometriosis Treatment Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Endometriosis Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Endometriosis Treatment Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Endometriosis Treatment Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Endometriosis Treatment Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Endometriosis Treatment Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Endometriosis Treatment Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Endometriosis Treatment Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Endometriosis Treatment Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Endometriosis Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Endometriosis Treatment Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Endometriosis Treatment Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Endometriosis Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Endometriosis Treatment Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Endometriosis Treatment Drugs

Table 66. Key Market Challenges & Risks of Endometriosis Treatment Drugs

Table 67. Key Industry Trends of Endometriosis Treatment Drugs

Table 68. Endometriosis Treatment Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Endometriosis Treatment Drugs Distributors List

Table 71. Endometriosis Treatment Drugs Customer List

Table 72. Global Endometriosis Treatment Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Endometriosis Treatment Drugs Sales Market Forecast by Region

Table 74. Global Endometriosis Treatment Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Endometriosis Treatment Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Endometriosis Treatment Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Endometriosis Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Endometriosis Treatment Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Endometriosis Treatment Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Endometriosis Treatment Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Endometriosis Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Endometriosis Treatment Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Endometriosis Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Endometriosis Treatment Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Endometriosis Treatment Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Endometriosis Treatment Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Endometriosis Treatment Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Endometriosis Treatment Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Endometriosis Treatment Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Endometriosis Treatment Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Endometriosis Treatment Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. AbbVie Inc Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. AbbVie Inc Endometriosis Treatment Drugs Product Offered

Table 94. AbbVie Inc Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. AbbVie Inc Main Business

Table 96. AbbVie Inc Latest Developments

Table 97. Bayer AG Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer AG Endometriosis Treatment Drugs Product Offered

Table 99. Bayer AG Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Bayer AG Main Business

Table 101. Bayer AG Latest Developments

Table 102. AstraZeneca Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. AstraZeneca Endometriosis Treatment Drugs Product Offered

Table 104. AstraZeneca Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. AstraZeneca Main Business

Table 106. AstraZeneca Latest Developments

Table 107. Pfizer Inc Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer Inc Endometriosis Treatment Drugs Product Offered

Table 109. Pfizer Inc Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Pfizer Inc Main Business

Table 111. Pfizer Inc Latest Developments

Table 112. Teva Pharmaceutical Industries Ltd Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Offered

Table 114. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Teva Pharmaceutical Industries Ltd Main Business

Table 116. Teva Pharmaceutical Industries Ltd Latest Developments

Table 117. Ipsen Pharma Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Ipsen Pharma Endometriosis Treatment Drugs Product Offered

Table 119. Ipsen Pharma Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Ipsen Pharma Main Business

Table 121. Ipsen Pharma Latest Developments

Table 122. Myovant Sciences Ltd Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Myovant Sciences Ltd Endometriosis Treatment Drugs Product Offered

Table 124. Myovant Sciences Ltd Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Myovant Sciences Ltd Main Business

Table 126. Myovant Sciences Ltd Latest Developments

Table 127. Endoceutics, Inc Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Endoceutics, Inc Endometriosis Treatment Drugs Product Offered

Table 129. Endoceutics, Inc Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Endoceutics, Inc Main Business

Table 131. Endoceutics, Inc Latest Developments

Table 132. Debiopharm Group Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. Debiopharm Group Endometriosis Treatment Drugs Product Offered

Table 134. Debiopharm Group Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Debiopharm Group Main Business

Table 136. Debiopharm Group Latest Developments

Table 137. Mayne Pharma Group Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Mayne Pharma Group Endometriosis Treatment Drugs Product Offered

Table 139. Mayne Pharma Group Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Mayne Pharma Group Main Business

Table 141. Mayne Pharma Group Latest Developments

List of Figures

Figure 1. Picture of Endometriosis Treatment Drugs

Figure 2. Endometriosis Treatment Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Endometriosis Treatment Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Endometriosis Treatment Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Endometriosis Treatment Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Type

Figure 10. Product Picture of Others

Figure 11. Global Endometriosis Treatment Drugs Sales Market Share by Type in 2021

Figure 12. Global Endometriosis Treatment Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Endometriosis Treatment Drugs Consumed in Hospital Pharmacies

Figure 14. Global Endometriosis Treatment Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 15. Endometriosis Treatment Drugs Consumed in Retail Pharmacies

Figure 16. Global Endometriosis Treatment Drugs Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 17. Endometriosis Treatment Drugs Consumed in E-Commerce

Figure 18. Global Endometriosis Treatment Drugs Market: E-Commerce (2017-2022) & (K Units)

Figure 19. Endometriosis Treatment Drugs Consumed in Others

Figure 20. Global Endometriosis Treatment Drugs Market: Others (2017-2022) & (K Units)

Figure 21. Global Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)

Figure 22. Global Endometriosis Treatment Drugs Revenue Market Share by Application in 2021

Figure 23. Endometriosis Treatment Drugs Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Endometriosis Treatment Drugs Revenue Market Share by Company in 2021

Figure 25. Global Endometriosis Treatment Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Endometriosis Treatment Drugs Revenue Market Share by Geographic Region in 2021

Figure 27. Global Endometriosis Treatment Drugs Sales Market Share by Region (2017-2022)

Figure 28. Global Endometriosis Treatment Drugs Revenue Market Share by Country/Region in 2021

Figure 29. Americas Endometriosis Treatment Drugs Sales 2017-2022 (K Units)

Figure 30. Americas Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)

Figure 31. APAC Endometriosis Treatment Drugs Sales 2017-2022 (K Units)

Figure 32. APAC Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Europe Endometriosis Treatment Drugs Sales 2017-2022 (K Units)

Figure 34. Europe Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Endometriosis Treatment Drugs Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Americas Endometriosis Treatment Drugs Sales Market Share by Country in 2021

Figure 38. Americas Endometriosis Treatment Drugs Revenue Market Share by Country in 2021

Figure 39. United States Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Endometriosis Treatment Drugs Sales Market Share by Region in 2021

Figure 44. APAC Endometriosis Treatment Drugs Revenue Market Share by Regions in 2021

Figure 45. China Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Endometriosis Treatment Drugs Sales Market Share by Country in 2021

Figure 52. Europe Endometriosis Treatment Drugs Revenue Market Share by Country in 2021

Figure 53. Germany Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Endometriosis Treatment Drugs Revenue Market Share by Country in 2021

Figure 60. Egypt Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Endometriosis Treatment Drugs in 2021

Figure 66. Manufacturing Process Analysis of Endometriosis Treatment Drugs

Figure 67. Industry Chain Structure of Endometriosis Treatment Drugs

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390